Most people are aware of type 1 and type 2 diabetes, but did you know there is a type 3 diabetes as well! It is a more obscure term. Although it is not an accepted medical diagnosis, type 3 diabetes has been discussed in the literature as a possible relationship between insulin resistance in the brain and Alzheimer's disease. This link has been described to help explain how metabolic disorders impact brain health, causing cognitive decline and dementia.

What is Type 3 Diabetes?

Type 3 diabetes is more of a misnomer because it should not be confused with type 3c diabetes, which relates to pancreatic dysfunction. The term "type 3 diabetes," on the other hand, has been loosely used by some scientists to analogously propose that Alzheimer's disease is strongly implicated with insulin resistance in the brain.

This concept was conceptualized by Dr. Suzanne de la Monte and Dr. Jack Wands of Brown University in the year 2008. This hypothesis postulated that Alzheimer's disease may be called type 3 diabetes for it bears many similarities with glucose metabolism disorder type 2 diabetes. Their concept arises from the basic principle that insulin is fundamental to blood sugar regulation, but it is also the case with the brain. When brain cells become insulin-resistant, they lose access to glucose, impairing their function.

Research published in the Journal of Diabetes Science and Technology supports this hypothesis by indicating that insulin resistance can be a significant contributor to the occurrence of dementia, also referred to as Alzheimer's. The symptoms of memory loss and diminished reasoning are associated with impaired glucose metabolism in the body, especially in the cerebral tissue.

Symptoms of Type 3 Diabetes

Although type 3 diabetes is not a "medical term," its symptoms correlate well with Alzheimer's diseases that are known to reduce the ability to think in an efficient manner and bring down brain health. These signs are:

- Loss of memory, especially short-term.

- Poor judgment and judgment ability

- Failure in recognizing people or places familiar once.

- Failure in the process of reading, writing or processing numbers

- Anxiety, agitation, or mood changes.

- Disorganized thoughts or confusion

- Lack of impulse control

As the disease advances, patients may be afflicted with severe complications including an inability to swallow or control their bodily functions. In the final stages, most patients die from fatal complications such as aspiration pneumonia.

Causes of Type 3 Diabetes

This may not be well understood with regards to type 3 diabetes, or the exact link between insulin resistance and Alzheimer's disease. Some identified contributing factors include the following:

1. Insulin Resistance

Insulin acts as an important regulatory mechanism of brain functions such as memory and cognition. The reduction in insulin signaling may impair metabolism of brain cells, thus bringing about neurodegeneration.

2. Type 2 Diabetes

These diseases show a strong relationship and those individuals diagnosed with type 2 diabetes have double chances of getting Alzheimer's. In the two, the main causes can be chronic inflammation, oxidative stress, and a defect in glucose metabolism.

3. Environmental and Lifestyle Factors

Insulin resistance associated with obesity, stress, and an unhealthy diet is considered a cause that may increase the chances of Alzheimer's disease.

Researches in Frontiers in Neuroscience and The Lancet Neurology have also highlighted that drugs used for antidiabetic medication may be crucial for the prevention or at least slowing down the course of Alzheimer's.

Treatments for Type 3 Diabetes

In 2022, in a study in Pharmaceuticals, researchers studied biomarker uptake in brain regions implicated in the faulty uptake and metabolism of blood sugar in Alzheimer’s patients.

Emerging Therapies

Research into such treatments as intranasal insulin has also been promising. Intranasal delivery of insulin directly to the brain has been reported to enhance glucose uptake by brain cells, improve memory, and boost cognitive performance. While such clinical trials have been shown to be successful, additional research is needed for safety and efficacy.

Medications

For patients being aggressive or agitated, antipsychotic drugs may be prescribed; however, therapies such as cognitive rehabilitation as well as cognitive stimulation therapy serve to preserve memory and executive function.

Lifestyle Interventions

Diet, exercise, and stress management are critical in preventing and managing insulin resistance. A review in the Journal of Alzheimer's Disease also highlighted the benefits of Kirtan Kriya meditation, which can regulate genes involved in insulin and glucose metabolism, improve sleep, and reduce inflammation.

Can Type 3 Diabetes Be Prevented?

Although type 3 diabetes is not officially recognized, its connection to Alzheimer’s disease underscores the importance of proactive measures for brain health. Some prevention strategies include:

1. Healthy Diet

Consuming a balanced diet rich in antioxidants, whole grains, and healthy fats may support brain health.

2. Regular Exercise

Physical activity improves insulin sensitivity, reduces inflammation, and enhances overall metabolic health.

3. Stress Reduction

Mindfulness practices, including meditation, have been shown to lower stress levels, which can reduce the risk of cognitive decline.

The term type 3 diabetes brings out the complex relationship between metabolic disorders and brain health. Even though it is not a recognized medical condition, the concept emphasizes the crucial role of insulin in brain function and its possible contribution to Alzheimer's disease. Continued research will hopefully provide hope for therapies such as intranasal insulin and lifestyle modifications.

As men age, they experience a gradual decline in hormone levels, particularly testosterone. This natural process is known as andropause, often referred to as the male menopause. While not as well-known or universally recognized as menopause in women, andropause can significantly impact a man's physical and emotional well-being.

Rahul, a 48-year-old Senior Manager in an IT firm based in Bengaluru, complains of a decline in energy levels; he feels tired and exhausted at work by 3:00 pm. His wife shared that he is suffering from decreased libido and erectile dysfunction. He also overthinks, because of which he remains under chronic stress. Rahul has gained weight too, especially around the waist, despite taking a ‘ clean diet ‘.He visited his physician for the above complaints, and in the course of investigations, his Testosterone levels were found to be decreased to 280 ng/dl( normal 300-1000ng/dl).

Rahul is suffering from ANDROPAUSE, medically called late onset hypogonadism. Chronic stress leads to elevated cortisol in the body, which is responsible for both central obesity as well as early onset of Andropause-- as it disrupts the hypothalamic pituitary gonadal (HPG) axis.

What Is Andropause?

Andropause refers to the age-related decline in testosterone levels and the accompanying symptoms experienced by men. Unlike menopause, which is a sudden cessation of reproductive function in women, andropause is a gradual decline in hormone production. It usually occurs in middle-aged or older men, typically starting in their 40s or 50s, although the onset and severity can vary from person to person.

Symptoms Of Andropause

The symptoms of andropause can vary widely among individuals. Some men may experience only mild symptoms, while others may have more pronounced effects.

• Decreased energy levels and fatigue: Men going through andropause often report a decrease in energy levels, feeling tired and fatigued even with adequate rest.
• Sexual changes: Many men experience a decline in sexual desire (libido) and may have difficulties achieving or maintaining erections (erectile dysfunction). Additionally, there might be a decrease in sexual spontaneity and a longer recovery time between sexual encounters.
• Mood changes: Andropause can cause mood swings, irritability, increased anxiety, and even depression in some individuals. These emotional changes may be attributed to hormonal fluctuations and the psychological impact of dealing with aging-related concerns.
• Muscle and bone changes: Testosterone plays a crucial role in maintaining muscle mass and bone density. During andropause, men may experience a decrease in muscle mass, strength, and bone density, potentially leading to increased frailty and the risk of osteoporosis.
• Changes in body composition: Andropause can contribute to an increase in body fat, particularly around the abdomen. This change in body composition can lead to a decrease in overall physical fitness and self-esteem.

Why Andropause Happens

The primary reason is the age-related decline in testosterone production. Testosterone levels typically decrease by about 1 per cent/per year after 30. Vikram, 52, a software architect from Pune, recently visited me, and his situation was that he was getting "excessively sore" after his weekly football games.

Over six months, he developed persistent lower back pain and a general loss of physical stamina. Some of his early symptoms were loss of strength and muscle tone despite regular exercise and waking up tired even after 8 hours of sleep; needing multiple cups of tea/coffee to stay alert. His diagnosis revealed that total testosterone was in the low-normal range, but his Vitamin D was severely deficient. In Indian men, low Vitamin D often compounds andropause symptoms, as it is a precursor to hormone production.

However, other factors can contribute to the onset and progression of andropause, including:

Lifestyle factors: Unhealthy lifestyle habits, such as poor diet, lack of exercise, excessive alcohol consumption, and smoking, can accelerate the decline in testosterone levels and exacerbate the symptoms of andropause.

Chronic health conditions: Certain chronic conditions, such as obesity, diabetes, hypertension, and cardiovascular disease, can affect hormone production and contribute to the development of andropause.

Medications and treatments: Certain medications, including some antidepressants, corticosteroids, and opioids, can interfere with testosterone production. Additionally, treatments like chemotherapy or radiation therapy for cancer can also impact hormone levels.

Psychological factors: Psychological stress, depression, and anxiety can have a reciprocal relationship with andropause. Hormonal changes can contribute to emotional disturbances, while emotional well-being can also influence hormone regulation.

Diagnosis

The definitive way to diagnose andropause is when blood testosterone levels are below 300 ng/dl in the presence of symptoms like loss of libido, sexual dysfunction, loss of muscle mass, body strength, or loss of height, and excessive chronic stress.

Treatment options

In India, gynecologists strictly treat female reproductive health. For "male menopause," the male equivalent specialist is the Andrologist. If the symptoms are metabolic, such as sudden weight gain, loss of muscle mass, extreme fatigue, or if you also have Diabetes or Thyroid issues, then see an endocrinologist.

Common treatments include:

Hormone replacement therapy (HRT): In some cases, testosterone replacement therapy may be recommended to address the hormonal imbalance associated with andropause. HRT can help alleviate symptoms such as low libido, fatigue, and mood changes. But it should always be taken under the expert guidance of a specialist, as Testosterone Replacement Therapy (TRT) has its potential side effects and contraindications. TRT is not for ALL.

• Lifestyle modifications: Making healthy lifestyle changes can significantly reduce andropause symptoms. Regular exercise, a balanced diet rich in essential nutrients, stress reduction techniques, and adequate sleep can help improve energy levels, mood, and overall well-being.

• Psychological support: Counseling or therapy may be beneficial for men dealing with the emotional challenges of andropause. Addressing psychological factors, learning coping mechanisms, and developing a positive mindset can help navigate this phase of life more effectively.

• Symptoms-based medication: Depending on the individual symptoms experienced during andropause, medications such as phosphodiesterase type 5 inhibitors (e.g., Viagra) may be prescribed to address erectile dysfunction, or antidepressants may be considered for mood-related concerns, but only under a doctor’s guidance.

Andropause is a natural process that many men experience as they age. It involves a gradual decline in testosterone levels and can manifest in various physical and emotional symptoms. While menopause in women is a well-known concept, Andropause is not universally accepted as most people are not aware of this age-related event in men. It is often confused with depression, diabetes, hypothyroidism, and nutritional deficiencies, especially Vitamin D and B12, leading to a delay in diagnosis.

Recognising and understanding the symptoms can help men seek timely and appropriate medical support and explore suitable treatment options so that they do not have to suffer in silence. Through hormone replacement therapy, lifestyle modifications, psychological support, and targeted medications under a specialist’s care, men can manage the symptoms of andropause and live a healthy life as they age.

(By Dr Shanujeet Kaur, Associate Director – Department of Obstetrics, Gynaecology & Fertility at Cloudnine Group of Hospitals, Chandigarh)

Healthcare is one of the most fundamental pillars of human dignity. Yet, in India, the public’s trust in our health systems remains fragile, especially when it comes to services as sensitive and life-critical as blood transfusion. Patients, often in their most vulnerable moments, find themselves dependent on systems they may not fully understand and in which they often feel they have limited voice or agency.

This must change. Healthcare governance, including blood transfusion services, must be democratized—rooted in transparency, community engagement, and citizen accountability. Patients are not passive recipients of services; they are stakeholders who must be empowered to demand safety, quality, and fairness as a matter of right.

World Blood Donor Day is more than a tribute to voluntary donors - it is a reminder that safe and timely access to blood remains a public health responsibility. While celebrating the generosity of blood donors, the day also calls for stronger systems, higher safety standards, and greater public awareness to ensure that every patient receives blood that is safe, tested, and accessible without compromise. In a country like India, where demand often outpaces awareness, the conversation must extend beyond donation to accountability and patient rights.

Trust Deficit in Blood Services

Today, most citizens remain unaware of where their blood comes from, how it is tested, or whether adequate safety protocols are followed. The opacity in public hospitals and rural health facilities fuels confusion, vulnerability, and, tragically, irreversible harm. For patients who are transfusion dependent, such as those living with thalassemia, the risks of unsafe or delayed blood are not abstract but a daily reality.

This lack of transparency widens the trust deficit between citizens and institutions. Unless we rebuild trust through openness and accountability, no amount of infrastructure investment alone will suffice.

Why Patients Must Demand Safe Blood

One of the central issues is that patients and families often accept unsafe or unverified blood simply because they have no choice, or because they are unaware of the risks. This needs a radical shift. The public must be educated and encouraged to demand safe blood—blood that is tested, traceable, and certified.

Public awareness campaigns should not only encourage voluntary donation but also educate citizens about the hazards of unsafe blood, the need and availability of advanced testing technologies like Nucleic Acid Testing (NAT), and their right to access blood that meets the highest safety standards. NAT ensures the highest level of blood safety by detecting infections such as HIV, HBV, and HCV and other transfusion-transmitted-infections (TTIs) even during the window period (early detectable phase), as against the conventional methods, drastically reducing the risk of TTIs.

Its adoption creates a triple-win—protecting patients, empowering providers with global safety standards, and strengthening the nation’s public health and productivity. A well-informed public is not merely a beneficiary of reforms—they are a powerful driver of them.

A Multi-Pronged Pathway to Reform

We need citizen-centric oversight mechanisms through community-based monitoring committees and grievance redressal platforms where patients and their families can report unsafe practices, delays, or discrimination. These committees must be linked to state and national health authorities with the power to escalate serious lapses.

India must move toward a digitized, transparent blood inventory and tracking system, where every unit of blood is traceable—from donor to recipient. Donors should know how their blood is tested and where it goes, while recipients should know the origin, safety certification, and screening history of the blood they receive. Transparency will not only reduce corruption and mismanagement but also significantly boost public confidence.

Grassroots-level health education must be scaled up. Citizens should be taught not only to donate blood voluntarily but also to demand accountability from institutions. Awareness should extend to understanding why advanced technologies like NAT strengthen safety by safeguarding against transfusion-transmitted infections, and why public pressure can accelerate their wider adoption.

Policies must begin with the patient at the center. For thalassemia patients, consistent and uniform standards of care should be guaranteed across all states and institutions, whether private or public. Patients cannot be left at the mercy of geography or institutional capacity.

Infrastructure alone cannot ensure safe blood; skilled hands and informed minds must accompany it. Doctors, nurses, and technicians must be trained rigorously in advanced screening protocols, transfusion practices, and infection prevention. Regular refresher courses and accreditation systems should be instituted so that every professional handling blood understands the stakes—not just in terms of patient safety, but also in upholding global benchmarks of public health.

Good Governance is Good Health

Good governance in healthcare begins with accountability to the people. We must treat citizens as partners, not dependents, in shaping the healthcare system. The efforts of civil society groups such as the Thalassemia Patients Advocacy Group (TPAG) demonstrate how collaboration between patient communities and government can yield powerful change. These models of partnership should be institutionalized and expanded.

Conclusion: A Call to Action

Safe blood is not a privilege—it is a right. Patients must be educated, empowered, and encouraged to demand it. Systems must step up to ensure it. And policymakers must ensure that transparency and accountability are non-negotiable in the governance of blood services.

If India is to strengthen public trust in healthcare, it must begin with the basics—with the very blood that sustains life. By building transparent systems, informed citizens, and patient-first policies, we can ensure that every unit of blood in India is not only medically sound but also ethically and democratically robust. Healthcare reform is not sustainable without public trust. And public trust cannot exist without safe blood.

One of the main reasons diseases like Shigella, Nipah virus, and West Nile Fever get noticed is Kerala’s relatively efficient healthcare system, which extends all the way down to the grassroots level, where diseases can be diagnosed, treated, and reported — then forwarded through scientific publications for worldwide scrutiny and knowledge sharing.

Shigella Outbreak

Shigella is a fast-spreading bacterial diarrheal disease that may sometimes lead to bloody dysentery, destruction of blood cells, kidney damage, and, rarely, encephalopathy, which can be fatal.

Shigella outbreaks typically occur in clusters, where a few individuals consume contaminated food or water or come into contact with an infected individual, as can easily happen in an Anganwadi, where children play with the same toys and touch each other in the course of play. Besides, it is difficult to get children to wash their hands as adults do.

In most cases, Shigella causes a mild illness, but in children under the age of five, it is known to cause more severe disease because of their limited immunity. Because it is a bacterial illness, it can be treated with antibiotics, chosen based on the type and resistance pattern of the bacteria found in the particular outbreak.

Antimicrobial resistance is a worldwide challenge, but in India, Shigella strains are not as resistant as those found in the West. Ensuring safe food and clean drinking water, and avoiding contamination of drinking water with sewage — especially due to flooding during monsoons — is the way to prevent outbreaks from occurring.

Nipah Virus Outbreak

Nipah outbreaks are familiar to the people of Kerala from a large outbreak in 2018, affecting about 20 people. In subsequent years, however, outbreaks have been well-controlled, with person-to-person spread effectively halted by early identification of patients, contact tracing, and isolation of high-risk contacts.

Nipah is a dangerous and deadly disease, particularly when it affects the brain. The mortality rate can be as high as 90% in some outbreaks, though in smaller series, the rates have been lower, which is attributed to early detection and prompt supportive care.

Nipah is a zoonotic disease, involving a spillover of the virus to humans from fruit bats. In many instances, the first case has turned out to be fatal. Caregivers may contract the disease from this person through close personal contact during the course of illness, especially if protective measures such as gloves and masks are not used. While the initial spillover may not always be preventable, Nipah countermeasures are largely about preventing further person-to-person spread through contact tracing.

Fortunately, despite its high death rate in affected individuals, Nipah is not a fast-spreading disease like influenza or Covid, and therefore, there is no need for public anxiety. Preventive measures include avoiding contact with bats and discarding any half-eaten fruit found on the ground beneath fruit trees.

West Nile Fever and Dengue

West Nile virus is spread by the Culex mosquito. In most instances, the infection is either asymptomatic or mild. In a small fraction, it goes on to infect the brain, in which case it behaves like other viral encephalitides. The Culex mosquito, which spreads West Nile virus, tends to bite in the early morning and at dusk, and requires sustained mosquito control measures throughout the year. These mosquitoes are particularly common in waterlogged and low-lying areas.

Dengue, on the other hand, is a viral disease caused by four different serotypes, spread by the Aedes mosquito. The dengue virus is capable of infecting the same person repeatedly. The second infection tends to be more severe and can rarely be fatal. Dengue symptoms can range from none to mild fever, to high fever with severe body ache, and in some cases, internal bleeding. There are no effective antiviral agents.

Countermeasures essentially involve controlling the vector — the Aedes mosquito, an aggressive, small, day-biting mosquito with distinctive black and white stripes along its abdomen, which lays eggs in non-salty water typically found within the premises of residential or commercial properties, and in blocked drains. These eggs can survive long dry spells.

As for the life cycle, the larval-to-adult development takes approximately 7–10 days under warm conditions. The mosquito is capable of living indoors, which means it can spread the virus from an infected individual to others living in the same building or premises.

Control Measures

Effective control of these infectious diseases involves sustained efforts at addressing the root causes, systematic public education, early case identification, and established public health strategies for preventing further spread.